Zinc oxide (ZnO NPs) synthesized from fungal extracts are primarily hexagonal in shape and measure between 34-55 nm.
The biosynthesized ZnO NPs effectively inhibited both Gram-positive and Gram-negative bacteria.
Antifungal activity of ZnO NPs was observed in a dose-dependent manner, achieving a high percentage of mycelial inhibition.
A significant amount of ZnO NPs (1 μg/mL) was internalized by cancer cells without affecting their morphology.
The synthesized ZnO NPs demonstrated significant against cancer cells at a concentration of 1 μg/mL.
Simplified
PURPOSE: The study aimed to find an effective method for fungal-mediated synthesis of zinc oxide using endophytic fungal extracts and to evaluate the efficiency of synthesized ZnO NPs as antimicrobial and anticancerous agents.
METHODS: Zinc oxide nanoparticles (ZnO NPs) were produced from zinc nitrate hexahydrate with fungal filtrate by the combustion method. The spectroscopy and microscopy techniques, such as ultraviolet-visible spectroscopy, Fourier transform infrared spectroscopy (FT-IR), powder X-ray diffraction (PXRD), scanning electron microscopy (SEM) with energy-dispersive X-ray spectroscopy (EDX), dynamic light scattering (DLS), and transmission electron microscopy (TEM) with selected area electron diffraction (SAED), were used to characterize the obtained product. Antibacterial activity on Gram-positive (and) and Gram-negative (and) samples was tested by broth microplate dilution technique. ZnO NPs antifungal activity was determined against plant pathogenic and regular contaminating fungi using the food-poison method. The anticancerous assay of the synthesized ZnO NPs was also investigated by cell uptake, MTT assay, and apoptosis assay. Staphylococcus aureus Bacillus cereus Pseudomonas aeruginosa Escherichia coli
RESULTS: The fungal synthesized ZnO NPs were pure, mainly hexagonal in shape and size range of 34-55 nm. The biosynthesized ZnO NPs could proficiently inhibit both Gram-positive and Gram-negative bacteria. ZnO NPs synthesized from fungal extract exhibited antifungal activity in a dose-dependent manner with a high percentage of mycelial inhibition. The cell uptake analysis of ZnO NPs suggests that a significant amount of ZnO NPs (1 μg/mL) was internalized without disturbing cancer cells' morphology. As a result, the synthesized ZnO NPs showed significant against cancer cells at 1 μg/mL concentration.
CONCLUSION: This fungus-mediated synthesis of ZnO NPs is a simple, eco-friendly, and non-toxic method. Our results show that the synthesized ZnO NPs are an excellent novel antimicrobial and anticancer agent. Further studies are required to understand the mechanism of the antimicrobial, anticancerous action of ZnO NPs and their possible genotoxicity.
Key numbers
34–55 nm
Size of ZnO NPs
Size range of ZnO synthesized from fungal extracts
1 μg/mL
Anticancer concentration
Concentration of ZnO NPs showing significant anticancer effects
Full Text
We can’t show the full text here under this license.
